Cargando…

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy

OBJECTIVE: To assess the efficacy of biologic drugs, beyond tumor necrosis factor- (TNF-) α inhibitors, in the management of noninfectious refractory scleritis, either idiopathic or associated with systemic immune-mediated disorders. Patients and Methods. This is a retrospective study assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabiani, Claudia, Sota, Jurgen, Sainz-de-la-Maza, Maite, Pelegrín, Laura, Emmi, Giacomo, Lopalco, Giuseppe, Iannone, Florenzo, Vannozzi, Lorenzo, Guerriero, Silvana, Gelmi, Maria Chiara, Rigante, Donato, Tosi, Gian Marco, Hernández-Rodríguez, José, Cantarini, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201583/ https://www.ncbi.nlm.nih.gov/pubmed/32410867 http://dx.doi.org/10.1155/2020/8294560

Ejemplares similares

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
por: Fabiani, Claudia, et al.
Publicado: (2019)

Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
por: Gentileschi, Stefano, et al.
Publicado: (2020)

Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review
por: Sota, Jurgen, et al.
Publicado: (2021)

Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease
por: Cattalini, Marco, et al.
Publicado: (2015)

Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis
por: Della Casa, Francesca, et al.
Publicado: (2022)

Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network
por: Sota, Jurgen, et al.
Publicado: (2021)

Update on the Medical Management of Gastrointestinal Behçet's Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
por: Bitossi, Alice, et al.
Publicado: (2019)

Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives
por: Lopalco, Giuseppe, et al.
Publicado: (2015)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

Scleritis: Differentiating infectious from non-infectious entities
por: Murthy, Somasheila I, et al.
Publicado: (2020)

Cytokine Signatures in Mucocutaneous and Ocular Behçet’s Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

Infliximab for the treatment of refractory scleritis
por: Doctor, Priyanka, et al.
Publicado: (2009)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
por: Vitale, Antonio, et al.
Publicado: (2013)

Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2015)

Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives
por: Rotondo, Cinzia, et al.
Publicado: (2015)

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence
por: Venerito, Vincenzo, et al.
Publicado: (2020)

Untangling the Web of Systemic Autoinflammatory Diseases
por: Rigante, Donato, et al.
Publicado: (2014)

Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network
por: Gaggiano, Carla, et al.
Publicado: (2021)

Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease
por: Vitale, Antonio, et al.
Publicado: (2020)

Refractory necrotizing scleritis successfully treated with adalimumab
por: Lawuyi, Lola E., et al.
Publicado: (2016)

Tofacitinib in Refractory Scleritis: A Case Series
por: Dey, Suvankar, et al.
Publicado: (2023)

Scleritis and sclerokeratitis associated with IgA vasculitis: A case series
por: Hernanz, I., et al.
Publicado: (2021)

Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011)

P36 A case of refractory IBD-related scleritis
por: Paterson-Brown, Lucy, et al.
Publicado: (2021)

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors
por: Barone, Michele, et al.
Publicado: (2018)

Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis
por: Cacciapaglia, Fabio, et al.
Publicado: (2022)

Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome
por: Cantarini, Luca, et al.
Publicado: (2017)

Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
por: Vitale, Antonio, et al.
Publicado: (2023)

Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa
por: Annicchiarico, Giuseppina, et al.
Publicado: (2015)

Caution Should be Used in the Recognition of Adult-Onset Autoinflammatory Disorders: Facts or Fiction?
por: Cantarini, Luca, et al.
Publicado: (2013)

Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience
por: Sota, Jurgen, et al.
Publicado: (2020)

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Pseudomonas aeruginosa scleritis initially presenting as idiopathic diffuse anterior scleritis
por: Agarwal, Shweta, et al.
Publicado: (2020)

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis
por: Chen, Binyao, et al.
Publicado: (2022)

Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study
por: Floris, Alberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1aa42f6p35mo9fnvcuja4mip38